Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic increased the use of telehealth within medicine. Data on sociodemographic and clinical characteristics associated with telehealth utilization among cancer surgical patients have not been well-defined. METHODS: Cancer patients who had a surgical oncology visit at the James Cancer Hospital in March 2020–May 2021 were included. Patient demographic and clinical characteristics were recorded; access to modern information technology was measured using the Digital Divide Index (DDI). A logistic regression model was used to assess odds of receiving a telehealth. RESULTS: Among 2942 patients, median DDI was 18.2 (interquartile range 17.4–22.1). Patients were most often insured through managed care (n = 1459, 49.6%), followed by Medicare (n = 1109, 37.7%) and Medicaid (n = 267, 9.1%). Overall, 722 patients (24.5%) received at least one telehealth visit over the study period. On multivariable analysis, age (odds ratio [OR] 0.89, 95% confidence interval [CI] 0.80–0.98 per 10-year increase), sex (male vs. female: OR 1.83, 95% CI 1.45–2.32), cancer type (pancreatic vs. breast: OR 9.19, 95% CI 6.38–13.23; colorectal vs. breast: OR 5.31, 95% CI 3.71–7.58), insurance type (Medicare vs. Medicaid: OR 1.58, 95% CI 1.04–2.41) and county of residence (distant vs. neighboring: OR 1.33, 95% CI 1.06–1.66) were associated with increased odds of receiving a telehealth visit. Patients from high DDI counties were not less likely to receive telehealth visits versus patients from low DDI counties (OR 1.15, 95% CI 0.85–1.57). CONCLUSIONS: Several patient sociodemographic and clinical characteristics had an impact on the likelihood of receiving a telehealth visit versus an in-person visit, suggesting that telehealth may not be equally accessible to all surgical oncology patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-022-12259-9.